tiprankstipranks
Ibio Inc (IBIO)
NASDAQ:IBIO
US Market
IBIO
Ibio
RESEARCH TOOLSreports
Want to see IBIO full AI Analyst Report?

Ibio (IBIO) Stock News & Sentiment

2,300 Followers
iBio Strengthens Board with Appointment of Dr. Stoner
Premium
Company Announcements
iBio Strengthens Board with Appointment of Dr. Stoner
12d ago
8K
IBIO
Validating iBio’s Antibody Platform: Buy Rating Driven by IBIO-600’s Differentiated Obesity Profile and Long-Acting Myostatin Inhibition
Premium
Ratings
Validating iBio’s Antibody Platform: Buy Rating Driven by IBIO-600’s Differentiated Obesity Profile and Long-Acting Myostatin Inhibition
1M ago
IBIO
iBio Advances to Clinical Stage With IBIO-600 Trial
Premium
Company Announcements
iBio Advances to Clinical Stage With IBIO-600 Trial
1M ago
8K
IBIO
Insiders Rock Asana, Ibio, Redwire, AFLAC, Sibanye Stillwater
Premium
Weekend Updates
Insiders Rock Asana, Ibio, Redwire, AFLAC, Sibanye Stillwater
2M ago
AFL
RDW
iBio (IBIO-610): Validated Activin E Mechanism, Strategic Trial Positioning, and Attractive Risk-Reward Support a Buy Rating
Premium
Ratings
iBio (IBIO-610): Validated Activin E Mechanism, Strategic Trial Positioning, and Attractive Risk-Reward Support a Buy Rating
2M ago
IBIO
Buy Rating on iBio Driven by Differentiated Activin-Targeting Antibody and Large PH-HFpEF Market Opportunity
Premium
Ratings
Buy Rating on iBio Driven by Differentiated Activin-Targeting Antibody and Large PH-HFpEF Market Opportunity
2M ago
IBIO
Buy Rating on iBio Driven by Promising IBIO-610 Obesity Data and Favorable Risk-Reward Profile
Premium
Ratings
Buy Rating on iBio Driven by Promising IBIO-610 Obesity Data and Favorable Risk-Reward Profile
2M ago
IBIO
More IBIO News >

IBIO News on the Web

LifeSci Capital Remains a Buy on Ibio (IBIO)
TipRanks News
Bullish
Leerink Partners Sticks to Their Buy Rating for Ibio (IBIO)
TipRanks News
Bullish
Oppenheimer Reaffirms Their Buy Rating on Ibio (IBIO)
TipRanks News
Bullish
Analysts Offer Insights on Healthcare Companies: MDxHealth (MDXH) and Ibio (IBIO)
TipRanks News
Bullish
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Ibio (IBIO), MaxCyte (MXCT) and Atea Pharmaceuticals (AVIR)
TipRanks News
Bullish
iBio reports Q3 EPS (7c), consensus (6c)
TipRanks News
Bullish
iBio Strengthens Board with Appointment of Dr. Stoner
TipRanks News
Neutral
Ibio (IBIO) Receives a Buy from Chardan Capital
TipRanks News
Neutral

News Score - Last 7 Days

Very Positive
IBIO
Sector Average
Media Buzz
This Week4 articles
Weekly Average0.75 articles
News Sentiment
This Week99%
Sector Average78%
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is IBIO’s Media Buzz Sentiment?
4 articles about IBIO were published this week. In an average week, 0.75 articles are published.
    What is IBIO’s weekly average amount of articles?
    In an average week, 0.75 articles about IBIO are published.
      What is IBIO’s News Sentiment?
      99% of articles about IBIO were positive this week, compared to its sector average of 78%.
        Healthcare Stocks that are Trending in the News
        DOCSDoximity
        AVAHAveanna Healthcare Holdings
        GOSSGossamer Bio
        CGENCompugen
        RLAYRelay Therapeutics
        Showing the stocks with the most bullish news sentiment over the past week